DE MARTINO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 384
AS - Asia 180
EU - Europa 149
AF - Africa 11
OC - Oceania 1
Totale 725
Nazione #
US - Stati Uniti d'America 378
SG - Singapore 136
IT - Italia 75
CN - Cina 34
IE - Irlanda 17
DE - Germania 14
NL - Olanda 12
CI - Costa d'Avorio 11
FI - Finlandia 11
CA - Canada 6
FR - Francia 5
UA - Ucraina 5
VN - Vietnam 4
IR - Iran 3
SE - Svezia 3
BE - Belgio 2
GB - Regno Unito 2
IN - India 2
BG - Bulgaria 1
CZ - Repubblica Ceca 1
HR - Croazia 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
Totale 725
Città #
Singapore 117
Chandler 77
Boardman 24
Millbury 23
Santa Clara 17
Ashburn 14
Des Moines 14
Nanjing 13
Naples 11
Amsterdam 10
Princeton 10
Arezzo 9
Formia 9
Lawrence 9
Napoli 9
Munich 8
Beijing 7
Wilmington 7
Aversa 6
Shenyang 6
Jacksonville 5
Dong Ket 4
Fort Worth 4
Ottawa 4
Boston 3
Dublin 3
Falls Church 3
Helsinki 3
Miami 3
Prineville 3
Springfield 3
Fairfield 2
Kronberg 2
Leawood 2
San Mateo 2
Tianjin 2
Waanrode 2
Washington 2
Abidjan 1
Amhertsburg 1
Ardabil 1
Augusta 1
Campagna 1
Changsha 1
Crispano 1
Dallas 1
Edinburgh 1
Houston 1
Huddinge 1
Jiaxing 1
Lappeenranta 1
Los Angeles 1
Norwalk 1
Oral 1
Paris 1
Pignola 1
Portici 1
Pune 1
Redwood City 1
Seattle 1
Shanghai 1
Sofia 1
Stockholm 1
Toronto 1
Villaricca 1
Wellington 1
Woodbridge 1
Zagreb 1
Totale 482
Nome #
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs 62
Role of Dicer1 in thyroid cell proliferation and differentiation 51
Characterization of inflammatory infiltrate of ulcerative dermatitis in C57BL/6NCrl-Tg(HMGA1P6)1Pg mice 41
HMGA1-pseudogene overexpression contributes to cancer progression 38
HMGA1-pseudogene expression is induced in human pituitary tumors 37
miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene 37
UBE2C is a transcriptional target of the cell cycle regulator FOXM1 34
HMGA1-pseudogene7 transgenic mice develop B cell lymphomas 33
UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines 32
HMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma 31
HMGA1 negatively regulates NUMB expression at transcriptional and post transcriptional level in glioblastoma stem cells 31
HMGA1-pseudogenes and cancer 30
HMGA1 induces EZH2 overexpression in human B-cell lymphomas 29
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs 29
The HMGA1-pseudogene7 shows oncogenic activity in vivo 24
Differential Expression of LncRNA in Bladder Cancer Development 23
miR-130b-3p Upregulation Contributes to the Development of Thyroid Adenomas Targeting CCDC6 Gene 22
The HMGA1 pseudogene 7 induces miR-483 and miR-675 upregulation by activating Egr1 through a ceRNA mechanism 20
New Anti-Cancer Strategies in Testicular Germ Cell Tumors 18
Emerging role of usp8, hmga, and non-coding rnas in pituitary tumorigenesis 17
Overexpression of HMGA1 Figures as a Potential Prognostic Factor in Endometrioid Endometrial Carcinoma (EEC) 16
The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness 13
HMGA and cancer: A review on patent literatures 13
HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas 11
miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update 10
Critical role of the high mobility group A proteins in hematological malignancies 9
MPPED2 is downregulated in glioblastoma, and its restoration inhibits proliferation and increases the sensitivity to temozolomide of glioblastoma cells 9
Long non-coding RNAs regulating multiple proliferative pathways in cancer cell 9
Further insights into testicular germ cell tumor oncogenesis: potential therapeutic targets 9
An update on microRNAs as potential novel therapeutic targets in testicular germ cell tumors 8
The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors 8
Testicular/paratesticular mesothelial tumours: Uncommon histopathologic entities in a very complex anatomical site 8
Characterization of HMGA1P6 transgenic mouse embryonic fibroblasts 7
Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma 6
Interplay between HMGA and TP53 in cell cycle control along tumor progression 6
Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas 6
HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas 5
HMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanism 5
Analysis of microsatellite instability (MSI) in pediatric gonadal and extra-gonadal germ cell tumors 4
Totale 801
Categoria #
all - tutte 4.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202037 0 0 0 0 4 1 0 17 0 3 11 1
2020/202139 0 2 9 3 2 5 3 0 2 0 9 4
2021/202294 1 0 0 0 1 3 1 4 17 7 20 40
2022/2023180 22 4 10 16 26 18 2 21 38 11 10 2
2023/2024182 10 18 6 12 3 6 1 14 0 7 61 44
2024/2025177 55 68 14 7 33 0 0 0 0 0 0 0
Totale 801